Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases, Parkinson's disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023

ウェアラブルインジェクターの世界市場予測(~2023年)

◆タイトル:Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases, Parkinson's disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023
◆商品コード:MAM-MD-6659
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年10月8日
◆ページ数:105
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、ウェアラブルインジェクターの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、タイプ別(オンボディ、オフボディ)分析、療法別(免疫腫瘍学、糖尿病、心血管疾患、パーキンソン病、サラセミア、原発性免疫不全症)分析、ウェアラブルインジェクターの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period. The growth of this market is primarily driven by the growing prevalence of chronic diseases (such as cancer, diabetes, and CVD); favorable reimbursement scenario in major markets; and technological advancements in injector devices. However, the preference for alternative drug delivery modes and a poor reimbursement structure in developing countries is expected to limit the adoption of wearable injector devices to a certain extent.
The market is segmented on the basis of type, therapy, and region. Based on type, the market is segmented into on-body and off-body injectors. The on-body wearable injectors segment is expected to account for the larger market share in 2018, while the off-body injectors segment is projected to witness the highest growth rate during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased adoption of off-body injectors.

Based on therapy, the global wearable injectors market is segmented into immune-oncology, diabetes, cardiovascular diseases, and other therapies (such as Parkinson’s disease, thalassemia, and primary immunodeficiency disease). The immuno-oncology segment is expected to account for the largest share of the market in 2018. The large share of this segment can be attributed to the high prevalence of cancer across the globe.

By region, the global market is segmented into North America, Europe, Asia Pacific, and the RoW. The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.

The global wearable injectors market is dominated by Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutic Corporation (US), and Valeritas (US). These players adopted growth strategies such as product launches, product approvals, agreements, and expansions to maintain and enhance their positions in the market. Other prominent players in the market include Ypsomed (Switzerland), Becton, Dickinson and Company (US), SteadyMed Therapeutics (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK).

【レポートの目次】

Table of Contents

1 Introduction (Page No. – 11)
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Wearable Injectors Market: Overview
4.2 Global Market, By Type, 2018 vs 2023
4.3 Geographic Analysis: Global Market, By Therapy
4.4 Geographic Snapshot: Global Market

5 Wearable Injectors Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Chronic Diseases
5.2.1.2 Favorable Reimbursement Scenario in Major Markets
5.2.1.3 Technological Advancements and Design Development
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Biologics and MABS
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Structure in Developing Countries

6 By Type (Page No. – 35)
6.1 Introduction
6.2 On-Body Injectors
6.3 Off-Body Injectors

7 By Therapy (Page No. – 39)
7.1 Introduction
7.2 Immuno-Oncology
7.3 Diabetes
7.4 Cardiovascular Diseases
7.5 Other Therapies

8 By Region (Page No. – 46)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 RoAPAC
8.5 Rest of the World

9 Competitive Landscape (Page No. – 74)
9.1 Overview
9.2 Market Share Analysis
9.3 Market Share Analysis, By Therapy
9.3.1 Immuno-Oncology
9.3.2 Amgen
9.3.3 Diabetes
9.3.4 Medtronic
9.3.5 Insulet Corporation
9.3.6 Cardiovascular Diseases
9.3.7 United Therapeutics
9.4 Competitive Scenario
9.4.1 Product Launches and Approvals
9.4.2 Expansions
9.4.3 Agreements, Collaborations, and Partnerships

10 Company Profiles (Page No. – 79)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 Amgen
10.2 Medtronic PLC
10.3 Insulet Corporation
10.4 Ypsomed
10.5 Becton, Dickinson and Company
10.6 Tandem Diabetes Care, Inc.
10.7 United Therapeutics Corporation
10.8 Valeritas, Inc.
10.9 Enable Injections
10.10 Steadymed Therapeutics
10.11 Sensile Medical (A Part of Gerresheimer)

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. – 98)
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details

List of Tables (46 Tables)

Table 1 Wearable Injectors (WI) Market, By Type, 2016–2023 (USD Billion)
Table 2 On-Body WI Market, By Country, 2016–2023 (USD Million)
Table 3 Off-Body WI Market, By Country, 2016–2023 (USD Million)
Table 4 Global Market, By Therapy, 2016–2023 (USD Billion)
Table 5 Global Market for Immuno-Oncology, By Country, 2016–2023 (USD Million)
Table 6 Insulin Devices Available for Diabetic Patients
Table 7 Global Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 8 Global Market for Cardiovascular Diseases, By Country, 2016–2023 (USD Million)
Table 9 Global Market for Other Therapies, By Country, 2016–2023 (USD Million)
Table 10 Global Market, By Region, 2016-2023 (USD Million)
Table 11 North America: Wearable Injectors Market, By Country, 2016-2023 (USD Million)
Table 12 North America: Market, By Therapy, 2016-2023 (USD Million)
Table 13 North America: Market, By Type, 2016-2023 (USD Million)
Table 14 US: Market, By Therapy, 2016-2023 (USD Million)
Table 15 US: Market, By Type, 2016-2023 (USD Million)
Table 16 Canada: Market, By Therapy, 2016-2023 (USD Million)
Table 17 Canada: Market, By Type, 2016-2023 (USD Million)
Table 18 Recent Developments in the Wearable Injectors Market in Europe, 2015–2018
Table 19 Europe: Market, By Country, 2016-2023 (USD Million)
Table 20 Europe: Market, By Therapy, 2016-2023 (USD Million)
Table 21 Europe: Market, By Type, 2016-2023 (USD Million)
Table 22 Germany: Market, By Therapy, 2016-2023 (USD Million)
Table 23 Germany: Market, By Type, 2016-2023 (USD Million)
Table 24 UK: Market, By Therapy, 2016-2023 (USD Million)
Table 25 UK: Market, By Type, 2016-2023 (USD Million)
Table 26 France: Wearable Injectors Market, By Therapy, 2016-2023 (USD Million)
Table 27 France: Market, By Type, 2016-2023 (USD Million)
Table 28 RoE: Market, By Therapy, 2016-2023 (USD Million)
Table 29 RoE: Market, By Type, 2016-2023 (USD Million)
Table 30 Asia Pacific: Market, By Country, 2016-2023 (USD Million)
Table 31 Asia Pacific: Market, By Therapy, 2016-2023 (USD Million)
Table 32 Asia Pacific: Market, By Type, 2016-2023 (USD Million)
Table 33 Japan: Wearable Injectors Market, By Therapy, 2016-2023 (USD Million)
Table 34 Japan: Market, By Type, 2016-2023 (USD Million)
Table 35 China: Market, By Therapy, 2016-2023 (USD Million)
Table 36 China: Market, By Type, 2016-2023 (USD Million)
Table 37 India: Market, By Therapy, 2016-2023 (USD Million)
Table 38 India: Market, By Type, 2016-2023 (USD Million)
Table 39 RoAPAC: Market, By Therapy, 2016-2023 (USD Million)
Table 40 RoAPAC: Wearable Injectors Market, By Type, 2016-2023 (USD Million)
Table 41 Conferences in Africa, Brazil, and the Middle East (2016–2018)
Table 42 RoW: Market, By Therapy, 2016-2023 (USD Million)
Table 43 RoW: Market, By Type, 2016-2023 (USD Million)
Table 44 Product Launches and Approvals
Table 45 Expansions
Table 46 Agreements, Collaborations, and Partnerships

List of Figures (30 Figures)

Figure 1 Wearable Injectors Market: Research Methodology Steps
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Immuno-Oncology Therapy Segment to Dominate the Wearable Injectors Market in 2018
Figure 8 On-Body Injectors to Account for the Largest Share of the Global Market in 2018
Figure 9 North America to Witness the Highest Market Growth During the Forecast Period
Figure 10 Growing Prevalence of Chronic Diseases is Driving Market Growth
Figure 11 On-Body Injectors Segment to Dominate the Market in 2018
Figure 12 Immuno-Oncology Segment to Command the Largest Share of the Market in 2018
Figure 13 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Wearable Injectors Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Global Market, By Type, 2018 vs 2023 (USD Billion)
Figure 16 Wearable Injectors Market, By Therapy, 2018 vs 2023 (USD Billion)
Figure 17 North America to Command the Largest Market Share in 2018
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 RoW: Market Snapshot
Figure 22 Strategies Adopted By Market Players (2014–2018)
Figure 23 Amgen: Company Snapshot (2017)
Figure 24 Medtronic PLC: Company Snapshot (2017)
Figure 25 Insulet Corporation: Company Snapshot (2017)
Figure 26 Ypsomed: Company Snapshot (2017)
Figure 27 BD: Company Snapshot (2017)
Figure 28 Tandem Diabetes Care: Company Snapshot (2017)
Figure 29 United Therapeutics Corporation: Company Snapshot (2017)
Figure 30 Valeritas: Company Snapshot (2017)

★調査レポート[ウェアラブルインジェクターの世界市場予測(~2023年)] ( Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases, Parkinson's disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023 / MAM-MD-6659) 販売に関する免責事項
[ウェアラブルインジェクターの世界市場予測(~2023年)] ( Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases, Parkinson's disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023 / MAM-MD-6659) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆